Cargando…
Erythropoietin – a potential tool in the treatment of depressive disorders?
INTRODUCTION: Depression is one of the leading causes of psychiatric disability across the globe because of its high prevalence and chronic, treatment resistant and recurrent nature. Erythropoietin (EPO), well known for its effects on blood cells, has also a key role in neuroprotection and cognitive...
Autores principales: | Simões, G., Jesus, S., Silva, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567545/ http://dx.doi.org/10.1192/j.eurpsy.2022.1440 |
Ejemplares similares
-
Therapeutic use of ayahuasca: a review of the evidence of its use in approaching depressive disorders
por: Simões, G., et al.
Publicado: (2022) -
Erythropoietin Pathway: A Potential Target for the Treatment of Depression
por: Ma, Chongyang, et al.
Publicado: (2016) -
BAD NEWS FOR HYPOCHONDRIACS: Covid-19 Associated Aggravation of Somatic Symptom Disorder with Psychotic Depression
por: Jesus, S., et al.
Publicado: (2022) -
Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder
por: Miskowiak, Kamilla W, et al.
Publicado: (2010) -
The Relationship between Plasma Erythropoietin Levels and Symptoms of Attention Deficit Hyperactivity Disorder
por: Kwon, Y.-J.
Publicado: (2023)